Industry analysis indicates the Artificial Intelligence in Genomics Market globally will advance at a 49.4% CAGR during 2024–2031.
Artificial Intelligence in Genomics covers market segmentation
the global artificial intelligence in genomics market is segmented on the basis of offering, application, technology type, functionality, and region. Rapid advancements and evolving end-user preferences are reshaping how technology and communications entities approach this space.
The market's upward path is propelled by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in technology and communications.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence (AI) in Genomics Market Snapshot
Chapter 4. Global Artificial Intelligence (AI) in Genomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Offering:
5.2.1. Software
5.2.2. Services
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:
6.2.1. Machine Learning
6.2.2. Deep Learning
6.2.3. Supervised Learning
6.2.4. Reinforcement Learning
6.2.5. Unsupervised Learning
6.2.6. Other Machine Learning Technologies
6.2.7. Other Technologies
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
7.2.1. Diagnostics
7.2.2. Drug Discovery & Development
7.2.3. Precision Medicine
7.2.4. Agriculture & animal Research
7.2.5. Other Applications
Chapter 8. Market Segmentation 4: By Functionality Estimates & Trend Analysis
8.1. By Functionality & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Functionality:
8.2.1. Genome Sequencing
8.2.2. Gene Editing
8.2.3. Clinical Workflows
8.2.4. Predictive Genetic Testing & Preventive Medicine
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By End User & Market Share, 2019 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
9.2.1. Pharmaceutical & Biotech Companies
9.2.2. Healthcare Providers
9.2.3. Research Centers, Academic Institutes & Government Organizations
9.2.4. Other End-Users
Chapter 10. Artificial Intelligence (AI) in Genomics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Offering, 2024- 2031
10.1.2. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Technology, 2024- 2031
10.1.3. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Application, 2024- 2031
10.1.4. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Functionality, 2024- 2031
10.1.5. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By End User, 2024- 2031
10.1.6. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts by country, 2024- 2031
10.2. Europe
10.2.1. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, 2024- 2031
10.2.2. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, 2024- 2031
10.2.3. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, 2024- 2031
10.2.4. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, 2024- 2031
10.2.5. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, 2024- 2031
10.2.6. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.3. Asia Pacific
10.3.1. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, 2024- 2031
10.3.2. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, 2024- 2031
10.3.3. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, 2024- 2031
10.3.4. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, 2024- 2031
10.3.5. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, 2024- 2031
10.3.6. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.4. Latin America
10.4.1. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, (US$ Million) 2024- 2031
10.4.2. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2024- 2031
10.4.3. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, (US$ Million) 2024- 2031
10.4.4. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, (US$ Million) 2024- 2031
10.4.5. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, (US$ Million) 2024- 2031
10.4.6. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, (US$ Million) 2024- 2031
10.5.2. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2024- 2031
10.5.3. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, (US$ Million) 2024- 2031
10.5.4. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, (US$ Million) 2024- 2031
10.5.5. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, (US$ Million) 2024- 2031
10.5.6. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. AI Therapeutics, Inc.,
11.2.2. Ares Genetics GmbH,
11.2.3. BenevolentAI,
11.2.4. BioSymetrics,
11.2.5. Cambridge Cancer Genomics (UK),
11.2.6. Clover Therapeutics,
11.2.7. Congenica Ltd,
11.2.8. Coral Genomics,
11.2.9. CureMatch, Inc.,
11.2.10. Cyclica Inc.,
11.2.11. Data4Cure, Inc,
11.2.12. Deep Genomics,
11.2.13. Desktop Genetics Ltd.,
11.2.14. Diploid (Belgium),
11.2.15. DNAnexus,
11.2.16. Emedgene,
11.2.17. Empiric Logic,
11.2.18. Engine Biosciences Pte. Ltd.,
11.2.19. Fabric Genomics, Inc.,
11.2.20. FDNA Inc. (US),
11.2.21. Freenome Holdings, Inc.,
11.2.22. Genoox, Ltd.,
11.2.23. IBM (US),
11.2.24. LifebitAI,
11.2.25. Microsoft (Project Hanover),
11.2.26. MolecularMatch Inc. (US),
11.2.27. NVIDIA Corporation (US),
11.2.28. PrecisionLife Ltd,
11.2.29. Predictive Oncology,
11.2.30. SOPHiA GENETICS, Inc.,
11.2.31. Trace Genomics,
11.2.32. Verge Genomics,
11.2.33. WhiteLab Genomics,
11.2.34. WuXi Nextcode Genomics